Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLU - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TALDO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNC1I1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM219A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BLVRB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C17orf97 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAMD9L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C7orf77 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CAPNS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930489 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WWP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAP1L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on